KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Capital Expenditures (2016 - 2025)

Clorox (CLX) has 16 years of Capital Expenditures data on record, last reported at $42.0 million in Q4 2025.

  • For Q4 2025, Capital Expenditures fell 20.75% year-over-year to $42.0 million; the TTM value through Dec 2025 reached $206.0 million, down 9.65%, while the annual FY2025 figure was $220.0 million, 3.77% up from the prior year.
  • Capital Expenditures reached $42.0 million in Q4 2025 per CLX's latest filing, up from $36.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $99.0 million in Q2 2021 and bottomed at $24.0 million in Q3 2023.
  • Average Capital Expenditures over 5 years is $58.4 million, with a median of $54.0 million recorded in 2024.
  • Peak YoY movement for Capital Expenditures: skyrocketed 72.34% in 2021, then crashed 47.83% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $57.0 million in 2021, then fell by 26.32% to $42.0 million in 2022, then increased by 23.81% to $52.0 million in 2023, then rose by 1.92% to $53.0 million in 2024, then dropped by 20.75% to $42.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $42.0 million in Q4 2025, $36.0 million in Q3 2025, and $75.0 million in Q2 2025.